Select Page
Innovation: A Top Priority for the Life Sciences Industries

Innovation: A Top Priority for the Life Sciences Industries

Yesterday, FDA Commissioner Scott Gottlieb made a statement on the new steps that the FDA is taking to improve innovation in medical devices. Like we have seen by authorities around the world, helping patients get more timely access to new innovations and medicines...

Medical Device Quality and ISO 13485:2016 Certification

Published in 2016, ISO 13485:2016 is in its third edition. ISO 13485:2016 comes on the heels of the ISO 13485:2003. Beginning in March 2016, there is a three-year transition period which comes to an end on February 28th 2019. These regulatory requirements undergo...

Man vs Machine Translation: The Continued Debate

Quite a while ago we took a look at the role of machine translation (MT) in life science translations. It’s a hot topic of debate, and we can all see with a quick internet-based translation what the pitfalls are. These one-off quick translations of a block of...

The Evolving Regulatory Environment in Japan (PMDA)

At DIA in June of this year, Tatsuya Kondo, Chief Executive of Pharmaceuticals and Medical Devices Agency (PMDA) gave a presentation on the future activities of the PMDA in Japan. In the presentation, Kondo discusses Japan’s “Rational Medicine”...